Cargando…
RARE-28. The use of subcutaneous interferon in patients with craniopharyngioma: an institutional retrospective review
Current strategies for managing craniopharyngioma result in significant morbidity. Successful treatment with interferon alfa(INFα) after progression is reported in the literature. This retrospective review details our institutional experience with INFα in craniopharyngioma patients. Method: Between...
Autores principales: | Patil, Prabhumallikarjun, Gray, Rachel, Goldman-Yassen, Adam, Aguilera, Dolly, Castellino, Robert, Janss, Anna, Mazewski, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164804/ http://dx.doi.org/10.1093/neuonc/noac079.053 |
Ejemplares similares
-
RARE-17. Multi-institutional craniopharyngioma cohort highlights need for more comprehensive data collection on comorbidities and quality of life
por: Marshall, Emily, et al.
Publicado: (2022) -
RARE-32. Phase 0 and feasibility single-institution clinical trial of intravenous tocilizumab for adamantinomatous craniopharyngioma
por: Dorris, Kathleen, et al.
Publicado: (2022) -
RARE-02.RE-IRRADIATION FOR RECURRENT CRANIOPHARYNGIOMA
por: Foran, Sarah, et al.
Publicado: (2020) -
RARE-07. THE LANDSCAPE OF GENOMIC ALTERATIONS IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS
por: Khadka, Prasidda, et al.
Publicado: (2020) -
RARE-13. Clinical management and functional and survival outcomes in pediatric craniopharyngioma, a patient and family perspective
por: Marshall, Emily, et al.
Publicado: (2022)